title: Therapeutic potential of glutathione.
abstract: Reactive oxygen species, formed in various biochemical reactions, are normally scavenged by antioxidants. Glutathione in its reduced form (GSH) is the most powerful intracellular antioxidant, and the ratio of reduced to oxidised glutathione (GSH:GSSG) serves as a representative marker of the antioxidative capacity of the cell. Several clinical conditions are associated with reduced GSH levels which as a consequence can result in a lowered cellular redox potential. GSH and the redox potential of the cell are components of the cell signaling system influencing the translocation of the transcription factor NF kappa B which regulates the synthesis of cytokines and adhesion molecules. Therefore, one possibility to protect cells from damage caused by reactive oxygen species is to restore the intracellular glutathione levels. Cellular GSH concentration can be influenced by exogenous administration of GSH (as intravenous infusion or as aerosol), of glutathione esters or of GSH precursors such as glutamine or cysteine (in form of N-acetyl-L-cysteine, alpha-lipoic acid). The modulation of GSH metabolism might present a useful adjuvant therapy in many pathologies such as intoxication, diabetes, uremia, sepsis, inflammatory lung processes, coronary disease, cancer and immunodeficiency states.
authors.affiliation: Department of Surgery, University of Vienna, Austria.
authors.forename: R
authors.initials: R
authors.lastname: Exner
authors.forename: B
authors.initials: B
authors.lastname: Wessner
authors.forename: N
authors.initials: N
authors.lastname: Manhart
authors.forename: E
authors.initials: E
authors.lastname: Roth
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D017024:Chemotherapy, Adjuvant; D017074:Common Variable Immunodeficiency / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy; D016207:Cytokines / Q000187:drug effects* / Q000276:immunology; D003920:Diabetes Mellitus / Q000188:drug therapy; D005978:Glutathione / Q000276:immunology / Q000378:metabolism* / Q000627:therapeutic use*; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects*; D008171:Lung Diseases / Q000188:drug therapy; D015427:Reperfusion Injury / Q000188:drug therapy; D014511:Uremia / Q000188:drug therapy
chemical_list: D016207:Cytokines; D005978:Glutathione